Board Meeting13 Aug 2026, 06:33 pm
Bandaram Pharma Declares Un-Audited Q1 FY27 Results
AI Summary
Bandaram Pharma Packtech Limited announced its un-audited financial results for the quarter ended June 30, 2026. The Board of Directors also approved the re-appointment of Mr. Suryaprakasa Rao Bommisetti as an Independent Director for a second term of 5 years and M/s. M.M. Reddy & Co. as statutory auditors for three years. The Annual General Meeting for FY 2025-26 is scheduled for September 18, 2026.
Key Highlights
- Board approved un-audited financial results for Q1 FY27.
- Re-appointment of Independent Director approved for 5 years.
- Statutory auditors re-appointed for a 3-year term.
- AGM for FY 2025-26 scheduled for September 18, 2026.
- Director's Report for FY 2025-26 also approved.
Price Impact
More from BANDARAM